ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 754329 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 754329; 2) Community: the network communities that were significantly associated with the response to NSC 754329; 3) Molecule: the relationships between components within communities and NSC 754329; 4) MDR: the compounds that were significantly associated with the NSC 754329.

NSC Compound Enrichment Correlation
NSC 682996 Null 0.0392716453377535 0.39822368
NSC 685285 Null 0.0392716453377535 0.24766519
NSC 686554 9H-Quino[4,3,2-de][1,10]phenanthrolin-9-one, 2-(2-pyridinyl)- 0.0392716453377535 0.27364753
NSC 699934 Null 0.0392716453377535 0.37930608
NSC 700862 4H-Cyclopenta[c]thiophen-4-one, 1,3-dichloro- 5,6-dihydro-6-hydroxy- 0.0392716453377535 0.4621806
NSC 709974 Null 0.0392716453377535 0.33061396
NSC 718781 Erlotinib hydrochloride 0.0392716453377535 -0.15567482
NSC 720134 Null 0.0392716453377535 0.022810697
NSC 724783 [1,5-dimethyl-10-(trifluoromethyl)-11,14,15,16-tetraoxatetra cyclo[10.3.1.04,13.08,13]hexadec-9-en-9-yl]-N,N-bis{[1,5-dim ethyl-10-(trifluoromethyl)-11,14,15,16-tetraoxatetracyclo[10 .3.1.04,13.08,13 0.0392716453377535 0.45568657
NSC 726217 Combretastatin A4-analogue 0.0392716453377535 0.39761684
Total:87  Current:73    [First] [Prev] [Next] [Last]